The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma.

MLA

Chuma, Makoto, et al. “The Influence of Hepatitis B DNA Level and Antiviral Therapy on Recurrence after Initial Curative Treatment in Patients with Hepatocellular Carcinoma.” Journal of Gastroenterology, vol. 44, no. 9, 2009, pp. 991–99. EBSCOhost, https://doi.org/10.1007/s00535-009-0093-z.

APA

Chuma, M., Hige, S., Kamiyama, T., Meguro, T., Nagasaka, A., Nakanishi, K., Yamamoto, Y., Nakanishi, M., Kohara, T., Sho, T., Yamamoto, K., Horimoto, H., Kobayashi, T., Yokoo, H., Matsushita, M., Todo, S., & Asaka, M. (2009). The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma. Journal of Gastroenterology, 44(9), 991–999. https://doi.org/10.1007/s00535-009-0093-z

Chicago

Chuma, Makoto, Shuhei Hige, Toshiya Kamiyama, Takashi Meguro, Atsushi Nagasaka, Kazuaki Nakanishi, Yoshiya Yamamoto, et al. 2009. “The Influence of Hepatitis B DNA Level and Antiviral Therapy on Recurrence after Initial Curative Treatment in Patients with Hepatocellular Carcinoma.” Journal of Gastroenterology 44 (9): 991–99. doi:10.1007/s00535-009-0093-z.